We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...
When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...
At the 15mg dose, participants showed a sustained average weight loss of 22.9% during the three-year treatment. Credit: SB ...
The therapy, sold under the brand name Kebilidi, is a one-time treatment for children and adults with an ultra rare inherited ...
By the time she was treated, she was almost completely paralyzed, Monje said. The treatment worked so well that her tumor ...
The origin of many diseases such as Alzheimer's or Parkinson's can be found at the molecular level in our body, in other ...
Hosted on MSN19h
This biotech’s stock could double if its treatment for major depressive disorder succeeds, says MizuhoIts pipeline includes treatments for bipolar depression, agitation in Alzheimer’s disease, schizophrenia and Parkinson’s ...
Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback